ASAH2 and neoplasm: Studies with ASAH2 knockdown (ASAH2-/-) mice demonstrated that deletion of ASAH2 inhibited cell and tumor growth, both in vitro and in vivo, through the WNT/β-catenin, ERK, GSK-3β and Akt pathways [150,151].